If We become aware that We have collected Personal Data from anyone under the age of 18 without verification of parental consent, We take steps to remove that information from Our servers
A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered
Abrahamsson, M
Rob Berberian works with every patient to determine whether they are dealing with temporary shedding, underlying pattern hair loss, or a combination of both, an important distinction that shapes the entire treatment plan
Moreover, in animal models of neuroinflammation, GLP-1RAs have demonstrated antioxidant, antiapoptotic, and neurotrophic effects
High Success Rate: 59.3% of users lost at least 4 kg of their baseline body weight
